A Study of Melphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT02963493 · COMPLETED
Trial details
- NCT number
- NCT02963493
- Sponsor
- Oncopeptides AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-28
- Primary completion
- 2020-10-22
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.